The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Protagonist Therapeutics, Inc(NASDAQ:PTGX) 
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. It is developing PTG-300, an injectable hepcidin mimetic that is in Phase II clinical trial for the treatment of patients with polycythem...
Website: http://www.protagonist-inc.com
Founded: 2006
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology
Protagonist Therapeutics Days Payable Outstanding ttm (DPO)
Protagonist Therapeutics Days Receivable Outstanding ttm (DSO)
Protagonist Therapeutics Days Inventory Outstanding ttm (DIO)
Protagonist Therapeutics Op Cashflow Per Share ttm
Protagonist Therapeutics Free Cashflow Per Share ttm
Protagonist Therapeutics Cash Per Share ttm
Protagonist Therapeutics P/S ratio ttm
Protagonist Therapeutics (GAAP) P/E ratio ttm
Protagonist Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.